TORONTO, March 2, 2011 — York University researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.
Researchers in the university’s Faculty of Science & Engineering studied a tiny strand of our geneti…
Drug resistance is a major obstacle in curing ovarian cancer but new research from the Centenary Institute has discovered a treatment that kills ovarian cancer cells in a new way that can break the resistance mechanism. Published today in Autophagy…
Aurora, Colo. (Oct. 19, 2010) — Estrogen therapy used by menopausal women causes a type of ovarian cancer to grow five times faster, according to a new study by researchers at the University of Colorado Cancer Center.
Menopausal estrogen replace…
Aspirin may reduce ovarian cancer growth, a laboratory study has shown. The study, published in the October issue of the journal Obstetrics and Gynecology, demonstrated that aspirin inhibited ovarian tumor cell growth by as much as 68 percent. The higher the dosage of aspirin added to the culture of ovarian cancer cells, the more growth inhibition was observed.